---
figid: PMC7485256__fphys-11-00990-g005
figlink: pmc/articles/PMC7485256/figure/F5/
number: F5
caption: 'Liver disease follows a common pathway of progression which results in fibrogenesis
  that is both preceded and driven by LSEC capillarisation and dysfunction. This figure
  summarises the common disease pathways discussed in this review, highlighting various
  approaches for potential therapeutic intervention. These include: (1) molecules
  which maintain LSEC homeostasis, such as BMP9, statins and phosphodiesterase inhibitors;
  (2) anti-angiogenics which are also anti-inflammatory and anti-fibrotic, such as
  L1-10, AT-II inhibition and sorafenib; (3) anti-fibrotics, including anti-VAP1 and
  Hh inhibition; (4) and targets involved in leukocyte recruitment. LSEC, liver sinusoidal
  endothelial cells; HCC, hepatocellular carcinoma; BMP9, bone morphogenic protein
  9; VEGF, vascular endothelial growth factor; NO, nitric oxide; sGC, soluble guanylate
  cyclase; PDE, phosphodiesterase; AT-II, angiotensin II; VAP-1, vascular adhesion
  protein 1; Hh, hedgehog; HSC, hepatic stellate cell.'
pmcid: PMC7485256
papertitle: The Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and
  Cancer Within the Liver.
reftext: Alex L. Wilkinson, et al. Front Physiol. 2020;11:990.
pmc_ranked_result_index: '44388'
pathway_score: 0.9639885
filename: fphys-11-00990-g005.jpg
figtitle: Liver disease follows a common pathway of progression which results in fibrogenesis
  that is both preceded and driven by LSEC capillarisation and dysfunction
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7485256__fphys-11-00990-g005.html
  '@type': Dataset
  description: 'Liver disease follows a common pathway of progression which results
    in fibrogenesis that is both preceded and driven by LSEC capillarisation and dysfunction.
    This figure summarises the common disease pathways discussed in this review, highlighting
    various approaches for potential therapeutic intervention. These include: (1)
    molecules which maintain LSEC homeostasis, such as BMP9, statins and phosphodiesterase
    inhibitors; (2) anti-angiogenics which are also anti-inflammatory and anti-fibrotic,
    such as L1-10, AT-II inhibition and sorafenib; (3) anti-fibrotics, including anti-VAP1
    and Hh inhibition; (4) and targets involved in leukocyte recruitment. LSEC, liver
    sinusoidal endothelial cells; HCC, hepatocellular carcinoma; BMP9, bone morphogenic
    protein 9; VEGF, vascular endothelial growth factor; NO, nitric oxide; sGC, soluble
    guanylate cyclase; PDE, phosphodiesterase; AT-II, angiotensin II; VAP-1, vascular
    adhesion protein 1; Hh, hedgehog; HSC, hepatic stellate cell.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AGTR2
  - FAM126A
  - GDF2
  - FUT1
  - VEGFD
  - VEGFB
  - PGF
  - VEGFA
  - VEGFC
  - SGCB
  - PDE1A
  - PDE2A
  - PDE4A
  - PDE4D
  - PDE8A
  - PDE6B
  - PDE8B
  - PDE1C
  - PDE3A
  - PDE3B
  - PDE4B
  - PDE4C
  - PDE6A
  - PDE6C
  - PDE7A
  - PDE9A
  - PDE1B
  - PDE10A
  - PDE7B
  - PDE11A
  - TH
  - Alcohol
  - Sorafenib
  - 'NO'
  - Statins
  - Toxicity
  - "Fibrosis \x1F Steatosis"
  - Cirrhosis
genes:
- word: AT-Il
  symbol: AT2
  source: hgnc_alias_symbol
  hgnc_symbol: AGTR2
  entrez: '186'
- word: HCC
  symbol: HCC
  source: hgnc_alias_symbol
  hgnc_symbol: FAM126A
  entrez: '84668'
- word: BMP9
  symbol: BMP9
  source: hgnc_alias_symbol
  hgnc_symbol: GDF2
  entrez: '2658'
- word: HSC
  symbol: HSC
  source: hgnc_prev_symbol
  hgnc_symbol: FUT1
  entrez: '2523'
- word: VEGF/NO/sGC
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: VEGF/NO/sGC
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF/NO/sGC
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF/NO/sGC
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: VEGF/NO/sGC
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: VEGF/NO/sGC
  symbol: SGC
  source: hgnc_alias_symbol
  hgnc_symbol: SGCB
  entrez: '6443'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1A
  entrez: '5136'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE2A
  entrez: '5138'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4A
  entrez: '5141'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4D
  entrez: '5144'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE8A
  entrez: '5151'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6B
  entrez: '5158'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE8B
  entrez: '8622'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1C
  entrez: '5137'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE3A
  entrez: '5139'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE3B
  entrez: '5140'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4B
  entrez: '5142'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE4C
  entrez: '5143'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6A
  entrez: '5145'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE6C
  entrez: '5146'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE7A
  entrez: '5150'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE9A
  entrez: '5152'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE1B
  entrez: '5153'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE10A
  entrez: '10846'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE7B
  entrez: '27115'
- word: PDE
  symbol: PDE
  source: bioentities_symbol
  hgnc_symbol: PDE11A
  entrez: '50940'
- word: TH
  symbol: TH
  source: hgnc_symbol
  hgnc_symbol: TH
  entrez: '7054'
chemicals:
- word: Alcohol
  source: MESH
  identifier: D000431
- word: Sorafenib
  source: MESH
  identifier: C471405
- word: 'NO'
  source: ''
  identifier: ''
- word: Statins
  source: MESH
  identifier: D019821
diseases:
- word: Toxicity
  source: MESH
  identifier: D064420
- word: "Fibrosis \x1F Steatosis"
  source: MESH
  identifier: D005355
- word: Cirrhosis
  source: MESH
  identifier: D005355
figid_alias: PMC7485256__F5
redirect_from: /figures/PMC7485256__F5
figtype: Figure
---
